Maze Therapeutics, Inc. (MAZE)
NASDAQ:MAZE
Maze Therapeutics, Inc. (MAZE) Ownership Overview
12.09% Insiders
6.22% Mutual Funds
70.58% Other Institutional Investors
6.31% ETFs
4.81% Public Companies and
Individual Investors
The ownership structure of Maze Therapeutics, Inc. (MAZE) stock is a mix of institutional, retail, and individual investors. Approximately 83.11% of the company’s stock is owned by Institutional Investors, 12.09% is owned by Insiders, and 4.81% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jan 08, 2026 | xxxxxxxxxxxxx | $1148827 | |
Sep 16, 2025 | xxxxxxxxxxxxx | $463836 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $964573 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $19886400 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,424,758 | Insider | 11.27% | 260,551,127 | |
| 1,553,970 | Institution | 3.23% | 74,637,179 | |
| 1,382,252 | Institution | 2.87% | 66,389,564 | |
| 1,035,229 | Institution | 2.15% | 49,722,049 | |
| 943,961 | Institution | 1.96% | 45,338,447 | |
| 480,000 | Institution | 1.00% | 23,054,400 | |
| 378,015 | Institution | 0.79% | 18,156,060 | |
| 328,700 | Insider | 0.68% | 15,787,461 | |
| 324,041 | Institution | 0.67% | 15,563,689 | |
| 285,885 | Institution | 0.59% | 13,731,057 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,382,252 | Institution | 2.87% | 66,389,564 | |
| 324,041 | Institution | 0.67% | 15,563,689 | |
| 285,885 | Institution | 0.59% | 13,731,057 | |
| 220,596 | Institution | 0.46% | 10,595,226 | |
| 195,549 | Institution | 0.41% | 9,392,218 | |
| 141,643 | Institution | 0.29% | 6,803,113 | |
| 110,322 | Institution | 0.23% | 5,298,766 | |
| 65,900 | Institution | 0.14% | 3,165,177 | |
| 58,713 | Institution | 0.12% | 2,819,985 | |
| 46,833 | Institution | 0.10% | 2,249,389 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,152,614 | Institution | 2.40% | 50,230,918 | |
| 505,559 | Institution | 1.05% | 25,384,117 | |
| 229,373 | Institution | 0.48% | 9,996,075 | |
| 189,015 | Institution | 0.39% | 9,490,443 | |
| 137,068 | Institution | 0.28% | 7,104,920 | |
| 104,243 | Institution | 0.22% | 5,403,436 | |
| 102,111 | Institution | 0.21% | 4,449,997 | |
| 56,574 | Institution | 0.12% | 2,840,581 | |
| 56,423 | Institution | 0.12% | 2,832,999 | |
| 48,095 | Institution | 0.10% | 2,425,912 |
FAQ
Who Owns Maze Therapeutics, Inc. (MAZE)?
According to the latest TipRanks data, approximately 70.58% of the company's stock is held by institutional investors, 12.09% is held by insiders, and 4.81% is held by retail investors.
What percentage of Maze Therapeutics, Inc. (MAZE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 70.58% of Maze Therapeutics, Inc. (MAZE) stock is held by institutional investors.
What percentage of Maze Therapeutics, Inc. (MAZE) stock is held by retail investors?
According to the latest TipRanks data, approximately 4.81% of Maze Therapeutics, Inc. (MAZE) stock is held by retail investors.
Who owns the most shares of Maze Therapeutics, Inc. (MAZE)?
Third Rock Ventures IV, L.P. owns the most shares of Maze Therapeutics, Inc. (MAZE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.